Context.—The management of lobular neoplasia (LN) found on core biopsy is controversial
and ranges from obligatory surgical excision to clinical/imaging observation. Objective.—To …

Standardized recommendations for the management of lobular neoplasia in core biopsy
specimens are not established. The aim of our study was to define morphologic features of …

Background Management of patients with classic lobular carcinoma in situ diagnosed on
core needle biopsy remains controversial, in part because of clinicopathologic overlap with …

We evaluated the efficacy of using standard radiologic and histologic criteria to guide the
follow‐up of patients with lobular carcinoma in situ (LCIS), lobular neoplasia (LN), or atypical …

The appropriate follow-up and treatment for patients with a core biopsy diagnosis of lobular
neoplasia (atypical lobular hyperplasia or lobular carcinoma in situ) remains controversial …

Background Lobular neoplasia (LN) represents a spectrum of atypical proliferative lesions,
including atypical lobular hyperplasia and lobular carcinoma-in-situ. The need for excision …

Context.—Both atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) have
traditionally been considered to be risk factors for the development of invasive carcinoma …

PURPOSE: To retrospectively determine frequency of invasive cancer or ductal carcinoma in
situ (DCIS) at excisional biopsy in women with atypical lobular hyperplasia (ALH) or lobular …

Background Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …

There are no consensus guidelines for the management of lobular neoplasia diagnosed on
core biopsy as the highest risk factor for cancer. This study aimed to assess the risk of …